RxDoctor Payments Data

Ebony Copeland

Adolescent Medicine · Chicago, ILNPI 1548404031

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $49,239 of the $57,519 with a category attached, or 85.6%. 13 manufacturers reported payments, led by Merck at 45.5% of the total. Reporting peaked in 2019 at $21,966 and has fallen 99.0% since, to $220 in 2025. Among adolescent medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,519in general payments, 2019–2025

Across 159 payments — averaging $361.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$26K
  • Organon$17K
  • Gilead$14K
  • Johnson & Johnson$120
  • Novo Nordisk$57
  • Theratechnologies Inc.$53
  • plus $215 from 7 others

What the payments were for

  • Speaking & faculty fees$49,23986%
  • Travel & lodging$5,98910%
  • Food & beverage$2,2924%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,519 in reported general payments places this provider in the 95th percentile of 60 adolescent medicine providers in Illinois.

See all adolescent medicine providers in Illinois

Other adolescent medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →